nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—Endophthalmitis—Acamprosate—alcohol dependence	0.0486	0.0988	CcSEcCtD
Tafluprost—PTGFR—Small Ligand GPCRs—CNR1—alcohol dependence	0.042	0.0826	CbGpPWpGaD
Tafluprost—Eye pain—Disulfiram—alcohol dependence	0.0378	0.0768	CcSEcCtD
Tafluprost—Iritis—Citalopram—alcohol dependence	0.0365	0.0742	CcSEcCtD
Tafluprost—Eye pruritus—Citalopram—alcohol dependence	0.031	0.0631	CcSEcCtD
Tafluprost—Eyelid oedema—Citalopram—alcohol dependence	0.0275	0.0559	CcSEcCtD
Tafluprost—PTGS2—Eicosanoid Synthesis—GGT2—alcohol dependence	0.0225	0.0442	CbGpPWpGaD
Tafluprost—Photophobia—Acamprosate—alcohol dependence	0.0217	0.0442	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—CHRM2—alcohol dependence	0.0176	0.0347	CbGpPWpGaD
Tafluprost—Eye irritation—Citalopram—alcohol dependence	0.0162	0.033	CcSEcCtD
Tafluprost—Cataract—Citalopram—alcohol dependence	0.0146	0.0296	CcSEcCtD
Tafluprost—Asthma—Acamprosate—alcohol dependence	0.0145	0.0295	CcSEcCtD
Tafluprost—Nasopharyngitis—Naltrexone—alcohol dependence	0.0142	0.0289	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.0136	0.0268	CbGpPWpGaD
Tafluprost—Photophobia—Citalopram—alcohol dependence	0.013	0.0265	CcSEcCtD
Tafluprost—Dry eye—Citalopram—alcohol dependence	0.0128	0.0261	CcSEcCtD
Tafluprost—Urinary tract infection—Acamprosate—alcohol dependence	0.0126	0.0256	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—DRD4—alcohol dependence	0.0126	0.0247	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Other—CNR1—alcohol dependence	0.012	0.0236	CbGpPWpGaD
Tafluprost—Urinary tract infection—Naltrexone—alcohol dependence	0.0119	0.0242	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—HTR7—alcohol dependence	0.0117	0.023	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.0117	0.0229	CbGpPWpGaD
Tafluprost—Rhinitis—Acamprosate—alcohol dependence	0.0116	0.0237	CcSEcCtD
Tafluprost—Eye pain—Citalopram—alcohol dependence	0.0112	0.0227	CcSEcCtD
Tafluprost—PTGS2—Eicosanoid Synthesis—GGT1—alcohol dependence	0.0106	0.0209	CbGpPWpGaD
Tafluprost—Headache—Disulfiram—alcohol dependence	0.0105	0.0214	CcSEcCtD
Tafluprost—Eye disorder—Naltrexone—alcohol dependence	0.0103	0.0209	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00914	0.018	CbGpPWpGaD
Tafluprost—Vision blurred—Naltrexone—alcohol dependence	0.00902	0.0183	CcSEcCtD
Tafluprost—Nasopharyngitis—Citalopram—alcohol dependence	0.009	0.0183	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—OPRK1—alcohol dependence	0.00887	0.0175	CbGpPWpGaD
Tafluprost—Cough—Acamprosate—alcohol dependence	0.00883	0.018	CcSEcCtD
Tafluprost—Asthma—Citalopram—alcohol dependence	0.0087	0.0177	CcSEcCtD
Tafluprost—Cough—Naltrexone—alcohol dependence	0.00835	0.017	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—HTR2A—alcohol dependence	0.0082	0.0161	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00795	0.0156	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00783	0.0154	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.00766	0.0151	CbGpPWpGaD
Tafluprost—Nervous system disorder—Naltrexone—alcohol dependence	0.00766	0.0156	CcSEcCtD
Tafluprost—Urinary tract infection—Citalopram—alcohol dependence	0.00754	0.0153	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00751	0.0148	CbGpPWpGaD
Tafluprost—Dyspnoea—Acamprosate—alcohol dependence	0.00736	0.015	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00703	0.0138	CbGpPWpGaD
Tafluprost—Rhinitis—Citalopram—alcohol dependence	0.00698	0.0142	CcSEcCtD
Tafluprost—Dyspnoea—Naltrexone—alcohol dependence	0.00696	0.0142	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.00656	0.0129	CbGpPWpGaD
Tafluprost—Eye disorder—Citalopram—alcohol dependence	0.00651	0.0132	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.00624	0.0123	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00603	0.0119	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—OPRD1—alcohol dependence	0.00596	0.0117	CbGpPWpGaD
Tafluprost—PTGS2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00591	0.0116	CbGpPWpGaD
Tafluprost—Pruritus—Acamprosate—alcohol dependence	0.00584	0.0119	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—PDYN—alcohol dependence	0.00572	0.0112	CbGpPWpGaD
Tafluprost—Vision blurred—Citalopram—alcohol dependence	0.00571	0.0116	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.00555	0.0109	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—AVP—alcohol dependence	0.00554	0.0109	CbGpPWpGaD
Tafluprost—Pruritus—Naltrexone—alcohol dependence	0.00553	0.0112	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.00546	0.0107	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00535	0.0105	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—PDYN—alcohol dependence	0.00535	0.0105	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CRHR1—alcohol dependence	0.00532	0.0105	CbGpPWpGaD
Tafluprost—Cough—Citalopram—alcohol dependence	0.00529	0.0108	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.00521	0.0103	CbGpPWpGaD
Tafluprost—Headache—Acamprosate—alcohol dependence	0.00517	0.0105	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.00508	0.01	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.00508	0.01	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—OPRK1—alcohol dependence	0.00501	0.00987	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CHRM2—alcohol dependence	0.005	0.00983	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.00495	0.00974	CbGpPWpGaD
Tafluprost—Headache—Naltrexone—alcohol dependence	0.00489	0.00995	CcSEcCtD
Tafluprost—Nervous system disorder—Citalopram—alcohol dependence	0.00485	0.00987	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.00468	0.0092	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—HTR2A—alcohol dependence	0.00461	0.00906	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—OPRM1—alcohol dependence	0.00459	0.00903	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—OPRK1—alcohol dependence	0.00455	0.00896	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.00447	0.00879	CbGpPWpGaD
Tafluprost—Dyspnoea—Citalopram—alcohol dependence	0.00441	0.00897	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.00436	0.00857	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.00436	0.00857	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—NPY—alcohol dependence	0.00422	0.00831	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.00412	0.00811	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—HTR1B—alcohol dependence	0.00407	0.00802	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CRH—alcohol dependence	0.00407	0.00802	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—GGT1—alcohol dependence	0.00376	0.0074	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.00367	0.00721	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.00356	0.00701	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—DRD4—alcohol dependence	0.00356	0.00701	CbGpPWpGaD
Tafluprost—Pruritus—Citalopram—alcohol dependence	0.0035	0.00712	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—CNR1—alcohol dependence	0.0034	0.00669	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—OPRD1—alcohol dependence	0.00337	0.00663	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—DRD2—alcohol dependence	0.00332	0.00653	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—HTR7—alcohol dependence	0.00332	0.00653	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PDYN—alcohol dependence	0.00323	0.00636	CbGpPWpGaD
Tafluprost—Headache—Citalopram—alcohol dependence	0.0031	0.0063	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—OPRD1—alcohol dependence	0.00306	0.00602	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.00305	0.006	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CRHR1—alcohol dependence	0.003	0.00591	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PDYN—alcohol dependence	0.00293	0.00577	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CHRM2—alcohol dependence	0.00282	0.00556	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—AVP—alcohol dependence	0.00279	0.00549	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CRHR1—alcohol dependence	0.00273	0.00537	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—OPRK1—alcohol dependence	0.00269	0.00529	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—OPRM1—alcohol dependence	0.00259	0.0051	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CHRM2—alcohol dependence	0.00256	0.00505	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.00245	0.00481	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.00244	0.00479	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—NPY—alcohol dependence	0.00239	0.0047	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—OPRM1—alcohol dependence	0.00235	0.00463	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—HTR2A—alcohol dependence	0.00232	0.00457	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CRH—alcohol dependence	0.0023	0.00453	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR1B—alcohol dependence	0.0023	0.00453	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—NPY—alcohol dependence	0.00217	0.00426	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR1B—alcohol dependence	0.00209	0.00411	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CRH—alcohol dependence	0.00209	0.00411	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—DRD4—alcohol dependence	0.00201	0.00396	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CNR1—alcohol dependence	0.00192	0.00378	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR7—alcohol dependence	0.00187	0.00369	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—DRD2—alcohol dependence	0.00187	0.00369	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—POMC—alcohol dependence	0.00186	0.00365	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—DRD4—alcohol dependence	0.00183	0.0036	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—OPRD1—alcohol dependence	0.00181	0.00356	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CNR1—alcohol dependence	0.00174	0.00343	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDYN—alcohol dependence	0.00173	0.00341	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR7—alcohol dependence	0.0017	0.00335	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—DRD2—alcohol dependence	0.0017	0.00335	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—WASF2—alcohol dependence	0.00161	0.00317	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CRHR1—alcohol dependence	0.00161	0.00317	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AVP—alcohol dependence	0.00158	0.0031	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—WASF1—alcohol dependence	0.00154	0.00304	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CHRM2—alcohol dependence	0.00152	0.00298	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—EP300—alcohol dependence	0.00151	0.00297	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AVP—alcohol dependence	0.00143	0.00282	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—OPRM1—alcohol dependence	0.00139	0.00274	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADH6—alcohol dependence	0.00139	0.00273	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR2A—alcohol dependence	0.00131	0.00258	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NPY—alcohol dependence	0.00128	0.00252	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CRH—alcohol dependence	0.00124	0.00243	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR1B—alcohol dependence	0.00124	0.00243	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR2A—alcohol dependence	0.00119	0.00235	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADH1A—alcohol dependence	0.00115	0.00226	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—DRD4—alcohol dependence	0.00108	0.00212	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—POMC—alcohol dependence	0.00105	0.00206	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CNR1—alcohol dependence	0.00103	0.00203	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—DRD2—alcohol dependence	0.00101	0.00198	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR7—alcohol dependence	0.00101	0.00198	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADH4—alcohol dependence	0.000976	0.00192	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—POMC—alcohol dependence	0.000952	0.00187	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AVP—alcohol dependence	0.000847	0.00167	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000845	0.00166	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADH7—alcohol dependence	0.00083	0.00163	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GGT2—alcohol dependence	0.000796	0.00157	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000783	0.00154	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADH1B—alcohol dependence	0.000728	0.00143	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR2A—alcohol dependence	0.000704	0.00139	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MAOB—alcohol dependence	0.000603	0.00119	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—POMC—alcohol dependence	0.000563	0.00111	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GOT2—alcohol dependence	0.000521	0.00102	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALDH2—alcohol dependence	0.000513	0.00101	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000493	0.00097	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GOT1—alcohol dependence	0.000449	0.000884	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GOT2—alcohol dependence	0.000436	0.000858	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2E1—alcohol dependence	0.00041	0.000806	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GOT1—alcohol dependence	0.000376	0.00074	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GGT1—alcohol dependence	0.000376	0.00074	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EP300—alcohol dependence	0.000373	0.000734	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MAOA—alcohol dependence	0.000337	0.000663	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000327	0.000643	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—POMC—alcohol dependence	0.00022	0.000432	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EP300—alcohol dependence	0.000174	0.000342	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—EP300—alcohol dependence	0.000146	0.000287	CbGpPWpGaD
